Ingalls & Snyder LLC Has $2.47 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Ingalls & Snyder LLC lifted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 16.1% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,035 shares of the medical equipment provider’s stock after purchasing an additional 700 shares during the period. Ingalls & Snyder LLC’s holdings in Intuitive Surgical were worth $2,474,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Mirador Capital Partners LP grew its position in shares of Intuitive Surgical by 1.4% during the 3rd quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock worth $1,732,000 after buying an additional 50 shares during the period. Consolidated Planning Corp increased its stake in Intuitive Surgical by 17.4% in the third quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock valued at $3,979,000 after purchasing an additional 1,198 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund raised its holdings in shares of Intuitive Surgical by 617.1% during the second quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 89,069 shares of the medical equipment provider’s stock valued at $39,622,000 after purchasing an additional 76,649 shares during the period. Swiss National Bank boosted its position in shares of Intuitive Surgical by 0.3% during the 3rd quarter. Swiss National Bank now owns 1,052,800 shares of the medical equipment provider’s stock worth $517,209,000 after purchasing an additional 3,400 shares in the last quarter. Finally, ABLE Financial Group LLC acquired a new stake in shares of Intuitive Surgical in the 3rd quarter valued at about $604,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the company. Evercore ISI reaffirmed a “cautious” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Robert W. Baird increased their target price on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a report on Thursday, October 17th. Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their price target for the company from $522.00 to $650.00 in a research note on Monday. Stifel Nicolaus raised their price objective on shares of Intuitive Surgical from $475.00 to $525.00 and gave the company a “buy” rating in a research note on Friday, October 18th. Finally, Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $536.61.

Intuitive Surgical Stock Down 1.5 %

Intuitive Surgical stock traded down $8.34 during mid-day trading on Tuesday, reaching $534.51. 79,208 shares of the company’s stock were exchanged, compared to its average volume of 1,444,128. The business’s fifty day simple moving average is $510.03 and its 200 day simple moving average is $469.49. Intuitive Surgical, Inc. has a one year low of $304.50 and a one year high of $552.00. The firm has a market capitalization of $190.38 billion, a PE ratio of 87.28, a P/E/G ratio of 5.33 and a beta of 1.38.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. The company had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. On average, sell-side analysts forecast that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Insiders Place Their Bets

In other Intuitive Surgical news, CFO Jamie Samath sold 108 shares of the business’s stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total value of $58,542.48. Following the sale, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,746,819.42. The trade was a 1.22 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, General Counsel Gary Loeb sold 300 shares of the company’s stock in a transaction on Monday, September 9th. The shares were sold at an average price of $475.00, for a total value of $142,500.00. Following the transaction, the general counsel now directly owns 1,595 shares in the company, valued at $757,625. This represents a 15.83 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 51,023 shares of company stock valued at $26,384,247. Company insiders own 0.80% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.